Blockchain, consent and prosent for medical research
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Recent advances in medical and information technologies, the availability of new types of medical data, the requirement of increasing numbers of study participants, as well as difficulties in recruitment and retention, all present serious problems for traditional models of specific and informed consent to medical research. However, these advances also enable novel ways to securely share and analyse data. This paper introduces one of these advances—blockchain technologies—and argues that they can be used to share medical data in a secure and auditable fashion. In addition, some aspects of consent and data collection, as well as data access management and analysis, can be automated using blockchain-based smart contracts. This paper demonstrates how blockchain technologies can be used to further all three of the bioethical principles underlying consent requirements: the autonomy of patients, by giving them much greater control over their data; beneficence, by greatly facilitating medical research efficiency and by reducing biases and opportunities for errors; and justice, by enabling patients with rare or under-researched conditions to pseudonymously aggregate their data for analysis. Finally, we coin and describe the novel concept of prosent, by which we mean the blockchain-enabled ability of all stakeholders in the research process to pseudonymously and proactively consent to data release or exchange under specific conditions, such as trial completion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Where blockchain/DLT contributed, it did so by producing more traceable records of consent, amendments, access, and trial events when embedded within appropriate regulatory and institutional frameworks, not by independently delivering the measured outcome [52,56].”
From Blockchain for Digital Health Governance: Evidence Gap Map and Scoping Review (2026) · cites this paper as [52]
In the citing paper
“Blockchain/DLT systems may therefore be most relevant where governance itself is distributed and where multiple organizations, professionals, patients, researchers, regulators, or commercial actors must exchange, authorize, validate, or audit data without relying on a single central authority [15,52].”
From Blockchain for Digital Health Governance: Evidence Gap Map and Scoping Review (2026) · cites this paper as [52]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Decentralizing Privacy: Using Blockchain to Protect Personal Data
Zyskind, G., Nathan, O., & Pentland, A. '. (2015) · 2015 IEEE Security and Privacy Workshops · doi:10.1109/spw.2015.27 · Cited by 2,617
Blockchain distributed ledger technologies for biomedical and health care applications
Kuo, T.-T., Kim, H.-E., & Ohno-Machado, L. (2017) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocx068 · Cited by 1,350
Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review
Ford, J. G., Howerton, M. W., Lai, G. Y., Gary, T. L., Bolen, S., Gibbons, M. C., Tilburt, J., Baffi, C., Tanpitukpongse, T. P., Wilson, R. F., et al. (2008) · Cancer · doi:10.1002/cncr.23157 · Cited by 1,083
A Systematic Review of the Use of Blockchain in Healthcare
Hölbl, M., Kompara, M., Kamišalić, A., & Nemec Zlatolas, L. (2018) · Symmetry · doi:10.3390/sym10100470 · Cited by 780
Røttingen, J.-A., Regmi, S., Eide, M., Young, A. J., Viergever, R. F., Årdal, C., Guzman, J., Edwards, D., Matlin, S. A., & Terry, R. F. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61046-6 · Cited by 477
Aitken, M., de St. Jorre, J., Pagliari, C., Jepson, R., & Cunningham-Burley, S. (2016) · BMC Medical Ethics · doi:10.1186/s12910-016-0153-x · Cited by 346 · cited 1×
“21 22 Prosent could help further this trend by allowing data owners to identify each other and request data and/or participation of other citizens or scientists.”
BackgroundPrototype of running clinical trials in an untrustworthy environment using blockchain
Wong, D. R., Bhattacharya, S., & Butte, A. J. (2019) · Nature Communications · doi:10.1038/s41467-019-08874-y · Cited by 160
Mapping of Crowdsourcing in Health: Systematic Review
Créquit, P., Mansouri, G., Benchoufi, M., Vivot, A., & Ravaud, P. (2018) · Journal of Medical Internet Research · doi:10.2196/jmir.9330 · Cited by 135
Self-citationBlockchain protocols in clinical trials: Transparency and traceability of consent
Benchoufi, M., Porcher, R., & Ravaud, P. (2018) · F1000Research · doi:10.12688/f1000research.10531.5 · Cited by 129 · cited 1×
“8 Smart contracts could be used to freeze patient data or the progression to the next protocol phase, thus predicating the release of data on unequivocal documentation of consent.”
MethodSelf-citationBarriers to Clinical Research Participation Among African Americans
Luebbert, R., & Perez, A. (2016) · Journal of Transcultural Nursing · doi:10.1177/1043659615575578 · Cited by 113
Research works printed but not linked: 18
- Faden RR , Beauchamp TL , King NMP . A History and Theory of Informed Consent. New York: Oxford University Press, 1986.
- Benchoufi, 2017, Blockchain technology for improving clinical research quality, Trials, 18, 10.1186/s13063-017-2035-z · DOI · Paper page
- Hardjono T , Shrier DL , Pentland A . Trusted data : a new framework for identity and data sharing (Revised and expanded edition. ed. Cambridge, MA: The MIT, 2019. · doi:10.7551/mitpress/12439.001.0001
- Clauson K , Breeden E , Davidson C , et al . Leveraging Blockchain technology to enhance supply chain management in healthcare. Blockchain in healthcare today, 1. 2018. · DOI · Paper page
- National Academies of Sciences, Engineering and Medicine . Learning through CitizenScience. Washington, D.C: National Academies Press, 2018.
- El Emam, 2013, A review of evidence on consent bias in research, Am J Bioeth, 13, 42, 10.1080/15265161.2013.767958 · DOI
- Groenwold, 2013, How and when does consent bias research?, The American Journal of Bioethics, 13, 46, 10.1080/15265161.2013.767961 · DOI
- Porsdam Mann, 2016, Facilitating the ethical use of health data for the benefit of society: electronic health records, consent and the duty of easy rescue, Philos Trans A Math Phys Eng Sci, 374
- Ploug, 2016, Meta Consent - A Flexible Solution to the Problem of Secondary Use of Health Data, Bioethics, 30, 721, 10.1111/bioe.12286 · DOI · Paper page
- National Academies of Sciences, Engineering and Medicine . ‘Learning Through Citizen Science. Washington, D.C: National Academies Press, 2018.
- Riordan, 2015, Patient and public attitudes towards informed consent models and levels of awareness of electronic health records in the UK, Int J Med Inform, 84, 237, 10.1016/j.ijmedinf.2015.01.008 · DOI
- Nicholson, 2015, Recruitment and retention strategies in clinical studies with low-income and minority populations: progress from 2004-2014, Contemp Clin Trials, 45, 34, 10.1016/j.cct.2015.07.008 · DOI
- 10.1177/1740774515597701 · DOI
- Kesselheim, 2011, Characteristics of clinical trials to support approval of orphan vs nonorphan drugs for cancer, JAMA, 305, 10.1001/jama.2011.769 · DOI · Paper page
- Annemans, 2017, Recommendations from the European Working group for value assessment and funding processes in rare diseases (ORPH-VAL), Orphanet J Rare Dis, 12, 10.1186/s13023-017-0601-9 · DOI
- Viergever RF . ‘The mismatch between the health research and development (R&D) that is needed and the R&D that is undertaken: an overview of the problem, the causes, and solutions.’. Glob Health Action 2013;2013(6). · DOI
- Seife C . (2015) ‘Research Misconduct Identified by the US Food and Drug Administration’. JAMA Intern Med 2015;175(4). · DOI · Paper page
- Andrade, 2015, The primary outcome measure and its importance in clinical trials, J Clin Psychiatry, 76, e1320, 10.4088/JCP.15f10377 · DOI · Paper page
Cited by
Ethics of artificial intelligence in medicine
Savulescu, J., Giubilini, A., Vandersluis, R., & Mishra, A. (2024) · Singapore Medical Journal · doi:10.4103/singaporemedj.smj-2023-279 · Cited by 68
“The reason why they are treated differently by the algorithm is that that type of cancer is more prevalent in women, and therefore the algorithm is more effective when is trained with more data about women.”
Self-citationBlockchain for Digital Health Governance: Evidence Gap Map and Scoping Review
Yaghobian, S., Sulkowski, N., Galambos, G., Scarazzini, L., Maloumian, N., & Verhaeghe, S. (2026) · Journal of Medical Internet Research · doi:10.2196/96098 · Cited by 1
Metadata
- Authors
- Porsdam Mann, S., Savulescu, J., Ravaud, P., & Benchoufi, M.
- Affiliations
- Department of Communication, University of Copenhagen Faculty of Humanities, København, Denmark
- Faculty of Philosophy, Oxford Uehiro Centre for Practical Ethics, Oxford, UK
- Mailman School of Public Health, Columbia University, New York, New York, USA
- Clinical Epidemiology, Universite Paris Descartes Faculté de Médecine, Paris, Île-de-France, France
- Venue
- Journal of Medical Ethics
- Publisher
- BMJ
- Published
- 2020-05-04
- Volume
- 47
- Issue
- 4
- Pages
- 244-250
- ISSN
- 0306-6800
- 1473-4257
- Cited by
- 53
- References
- 10
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Blockchain, consent and prosent for medical research. https://app.cochat.ai/papers/10.1136/medethics-2019-105963
- The paper
- Porsdam Mann, S., Savulescu, J., Ravaud, P., & Benchoufi, M. (2021). Blockchain, consent and prosent for medical research. Journal of Medical Ethics. https://doi.org/10.1136/medethics-2019-105963
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.